New Human Immunodeficiency Virus (HIV) Vaccine Design

A recent advancement in HIV Vaccine design has been made by a research team from The Scripps Research Institute (TSRI). The structure of a protein on an HIV's surface called the envelope glycoprotein on previous studies at TSRI has been used to design a mimic of the viral protein from an HIV subtype C, that is responsible for many infections.

Related Links